Clinical Trial Update: A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing 1% versus 2% lignocaine for cough suppression and pain relief during flexible bronchoscopy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Lung Cancer
• Sarcoidosis
• Tuberculosis

Drugs mentioned

• Lignocaine (lidocaine) 1% and 2% (lidocaine)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Lung Cancer, Tuberculosis | Phase 2, Phase 3 | Status: COMPLETED